|
|
 |
| |
|
Home > Drug News > DataCore Technology Takes Expertise On The Road To Belgium
DataCore Technology Takes Expertise On The Road To Belgium
Exton, PA (PRWEB) October 4, 2005 -- DataCore Technology, a specialist in implementing electronic document management systems, announced that after his successful appearance at MRO World, Brian Sallade, President of DataCore Technology, will be addressing MRO MAXIMO Pharmaceutical Users at a conference on October 4, 2005 in Brussels, Belgium. He will be speaking about connecting engineering and maintenance management solutions to a crowd comprised of some of the largest pharmaceutical companies in the world.
Mr. Sallade will discuss how the integration of Cyco AutoManager Meridian and DataCore’s FDA Module with MRO MAXIMO will aid users in complying with FDA 21 CFR Part 11 and other GMP requirements. The combined solution provides a configurable environment with electronic signatures, controlled print stamping, enhanced security features, and a compliant audit trail. This enables engineering and maintenance groups to collaborate more easily and efficiently, while in turn reducing compliance risk, enhancing productivity, reducing validation costs, and increasing overall profitability.
Thanks to the success and widespread adoption of DataCore’s unique FDA module, their reputation as the go-to expert for FDA-related asset information management issues is steadily gaining momentum. This expertise has enabled the company to continue to add a growing number of tier-one companies in the pharmaceutical industry to their client portfolio. In presenting to the MAXIMO conference attendees, Sallade will be able to share this knowledge and offer a combined software solution with DataCore’s world class consulting services to professionals representing pharmaceutical companies from all over the world.
About DataCore Technology
DataCore Technology specializes in implementing Electronic Data Management solutions for energy, government, manufacturing, and pharmaceutical organizations to help improve time to market, reduce asset maintenance costs, and comply with government regulations. The company operates with the highest degree of integrity, provides quality products and services, and maintains a steadfast commitment to excellence.
Back to Drug News
|
|
|
|
|
|
|
|